Observational studyRheumatology international2018

Outcomes after rheumatoid arthritis patients complete their participation in a long-term observational study with tofacitinib combined with methotrexate: practical and ethical implications in vulnerable populations after tofacitinib discontinuation.

Diana I Pérez-Román et al.PubMed ↗Publisher ↗

No numbers read from the abstract.